Prescription drug · ANDA
Oxymorphone hydrochloride NDC 64896-696
Oxymorphone hydrochloride 7.5 mg/1 · Tablet, Film coated, Extended release · Oral · Amneal Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64896-696-01 | 64896069601 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-696-01)Marketed from Jan 2, 2013 | |
| 64896-696-03 | 64896069603 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-696-03)Marketed from Jan 2, 2013 | |
| 64896-696-08 | 64896069608 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-696-08)Marketed from Jan 2, 2013 | |
| 64896-696-13 | 64896069613 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-696-13)Marketed from Jan 2, 2013 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Oxymorphone hydrochloride
- Generic name (nonproprietary)
- oxymorphone hydrochloride
- Active ingredients
- Oxymorphone hydrochloride — 7.5 mg/1
- Dosage form
- Tablet, Film coated, Extended release
- Route
- Oral
- Labeler
- Amneal Pharmaceuticals LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 079087
- Marketing start
- Listing expires
- DEA schedule
- CII
- Other FDA classes
- Full Opioid Agonists (Mechanism)
- Identifiers
- Product ID 64896-696_4f08b804-ef2d-4c9b-8553-c2bc7fa1fd71SPL ID 4f08b804-ef2d-4c9b-8553-c2bc7fa1fd71SPL set ID 3f4e703a-e398-42fd-8759-e398c79955f1RxCUI 977874, 977894, 977902, 977909, 977915, 977923, 977929UNII 5Y2EI94NBC
- Pharmacologic class
- Opioid Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464896069601followed by a unit qualifier and the quantityPackage 64896-0696-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Oxymorphone Hydrochloride Extended-Release Tablets are indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids. Limitations of Usage Because of the risks of addiction, abuse, misuse, overdose and death, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions (5.1) ] , reserve opioid analgesics, including Oxymorphone Hydrochloride Extended-Release Tablets, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient mana…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 079087
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 7.5 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1315 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 15 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1316 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 30 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1317 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 5 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1231 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 10 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1232 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 20 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1233 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 40 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1234 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 10 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-697 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 5 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-695 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 40 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-701 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 15 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-698 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 20 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-699 |
| Oxymorphone hydrochloride | Oxymorphone hydrochloride 30 mg/1 | Tablet, Film coated, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-700 |
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.